[HTML][HTML] Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of …
Summary Background Salmonella enterica serovar Typhi (S Typhi) is responsible for an
estimated 20 million infections and 200 000 deaths each year in resource poor regions of …
estimated 20 million infections and 200 000 deaths each year in resource poor regions of …
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi …
C Jin, MM Gibani, M Moore, HB Juel… - Lancet (London …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Salmonella enterica serovar Typhi (S Typhi) is responsible for an estimated 20
million infections and 200 000 deaths each year in resource poor regions of the world …
million infections and 200 000 deaths each year in resource poor regions of the world …
[HTML][HTML] Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of …
C Jin, MM Gibani, M Moore, HB Juel, E Jones… - The Lancet, 2017 - Elsevier
Summary Background Salmonella enterica serovar Typhi (S Typhi) is responsible for an
estimated 20 million infections and 200 000 deaths each year in resource poor regions of …
estimated 20 million infections and 200 000 deaths each year in resource poor regions of …
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi …
C Jin, MM Gibani, M Moore, HB Juel… - Lancet (London …, 2017 - europepmc.org
Background Salmonella enterica serovar Typhi (S Typhi) is responsible for an estimated 20
million infections and 200 000 deaths each year in resource poor regions of the world …
million infections and 200 000 deaths each year in resource poor regions of the world …
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi …
C Jin, M Gibani, M Moore, H Juel, E Jones, J Meiring… - Lancet, 2017 - ora.ox.ac.uk
Salmonella enterica serovar Typhi (S Typhi) is responsible for an estimated 20 million
infections and 200 000 deaths each year in resource poor regions of the world. Capsular Vi …
infections and 200 000 deaths each year in resource poor regions of the world. Capsular Vi …
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi …
C Jin, MM Gibani, M Moore, HB Juel, E Jones… - 2017 - cabidigitallibrary.org
Abstract Background: Salmonella enterica serovar Typhi (S Typhi) is responsible for an
estimated 20 million infections and 200000 deaths each year in resource poor regions of the …
estimated 20 million infections and 200000 deaths each year in resource poor regions of the …
[HTML][HTML] Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of …
C Jin, MM Gibani, M Moore, HB Juel, E Jones… - The Lancet, 2017 - thelancet.com
Summary Background Salmonella enterica serovar Typhi (S Typhi) is responsible for an
estimated 20 million infections and 200 000 deaths each year in resource poor regions of …
estimated 20 million infections and 200 000 deaths each year in resource poor regions of …
[HTML][HTML] Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of …
C Jin, MM Gibani, M Moore, HB Juel… - Lancet (London …, 2017 - ncbi.nlm.nih.gov
Background Salmonella enterica serovar Typhi (S Typhi) is responsible for an estimated 20
million infections and 200 000 deaths each year in resource poor regions of the world …
million infections and 200 000 deaths each year in resource poor regions of the world …
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi …
C Jin, MM Gibani, M Moore, HB Juel, E Jones… - The …, 2017 - eprints.whiterose.ac.uk
Background Salmonella enterica serovar Typhi (S Typhi) is responsible for an estimated 20
million infections and 200 000 deaths each year in resource poor regions of the world …
million infections and 200 000 deaths each year in resource poor regions of the world …
[引用][C] Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella …
C Jin, MM Gibani, M Moore, HB Juel, E Jones… - The Lancet, 2017 - cir.nii.ac.jp
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of
typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised …
typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised …